Clinical trials : design, conduct, and analysis /
Saved in:
Author / Creator: | Meinert, Curtis L. |
---|---|
Edition: | 2nd ed. |
Imprint: | New York : Oxford University Press, c2012. |
Description: | xxxv, 665 p. : ill. ; 26 cm. |
Language: | English |
Series: | Monographs in epidemiology and biostatistics ; 39 Monographs in epidemiology and biostatistics ; v. 39. |
Subject: | Clinical Trials as Topic. Clinical trials. MEDICAL / Research. MEDICAL / Epidemiology. Clinical trials. |
Format: | Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/8737705 |
Table of Contents:
- Trials
- Part 1. Introduction
- 1. Introduction
- 2. The language of clinical trials
- 3. Types and classes of trials
- 4. The state and nature of trials
- 5. The activities of clinical trials
- 6. Coordinating and other resource centers in multicenter trials
- 7. Multi-study networks
- 8. Ethical principles and imperatives in clinical trials
- 9. Objectivity versus competency in clinical trials
- Part 2. Design principles and practices
- 10. Fundamentals of controlled clinical trials
- 11. Bias
- 12. Bias control
- 13. Variance control
- 14. The study treatments
- 15. Outcome measures
- 16. Sample size and power estimates
- 17. Randomization
- 18. Treatment masking
- 19. The study plan
- 20. Data collection considerations
- Part 3. Execution
- 21. Data collection forms
- 22. Start-up and maintenance procedures
- 23. Participant recruitment and enrollment
- 24. Patient followup, close out, and post trial followup
- 25. Midcourse changes and coping strategies
- 26. Adverse events (AEs)
- 27. Quality assurance
- Part 4. Data analysis
- 28. Basic data analysis and counting principles for primary results publications
- 29. Study datasets
- 30. Basic data analysis procedures
- 31. Questions concerning the design, analysis, and interpretation of clinical trials
- 32. Treatment effects monitoring
- 33. Issues in treatment effects monitoring
- 34. Subgroup analyses
- Part 5. Organization and management
- 35. Funding
- 36. Organizational design and structure
- 37. Study governance
- 38. Study organizational structures and meetings
- 39. Regulations, requirements, policies, and guidelines
- Part 6. Publication
- 40. The publication imperative
- 41. Presentation, publication, information, and data access policies
- 42. Preparation of study publications
- 43. Document and report production
- 44. Reading reports of trials
- Part 7. Miscellaneous
- 45. Scientific integrity
- 46. Transgressions of trialists
- 47. Homogeneity versus heterogeneity in trials
- 48. Meta-analysis
- 49. The University Group Diabetes Program (UGDP)
- 50. Training trialists
- 51. Comparative effectiveness research (CER) and clinical trials
- 52. Readings and reference materials
- Part 8. Appendices
- A. Glossary of definitions
- B. Terminology usage and recommendations
- C. Medical research codes of ethics
- D. Teaching questions and answers
- E. Aids for trialists
- F. Data items and forms illustrations
- G. Randomization illustrations
- H. Activities by stage of trial
- I. Sketches of trialsYear 2006 publications in NEJM, JAMA, Br Med J, and Lancet
- J. Sample study documents
- K. User datasets
- L. Abbreviations
- References
- Index